SCOPUS 정보 검색 플랫폼

Volumn 59, Issue 4, 2015, Pages 2086-2093

Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors

(7) Yeo, Kim Long a Chen, Yen Liang a Xu, Hao Ying a Dong, Hongping a Wang, Qing Yin a Yokokawa, Fumiaki a Shi, Pei Yong a

a NOVARTIS INSTITUTE FOR TROPICAL DISEASES (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BREQUINAR; INX 08189; NUCLEOSIDE ANALOG; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS RNA; ANTIVIRUS AGENT; BETA INTERFERON; DEHYDROOROTATE DEHYDROGENASE; DRUG COMBINATION; INTERFERON INDUCING AGENT; NUCLEOSIDE; OXIDOREDUCTASE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL STRESS; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DENGUE VIRUS 2; DRUG POTENCY; DRUG POTENTIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PYRIMIDINE SYNTHESIS; VIRUS INHIBITION; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; DENGUE VIRUS; DRUG COMBINATION; DRUG EFFECTS; HEK293 CELL LINE;

ANTIVIRAL AGENTS; CELL LINE; DENGUE VIRUS; DRUG COMBINATIONS; DRUG SYNERGISM; HEK293 CELLS; HUMANS; INTERFERON INDUCERS; INTERFERON-BETA; NUCLEOSIDES; OXIDOREDUCTASES; RIBAVIRIN; VIRUS REPLICATION;

EID: 84949114816 PISSN: 00664804 EISSN: 10986596 Source Type: Journal
DOI: 10.1128/AAC.04779-14 Document Type: Article

Times cited : (51)

References (45)

1
- 84876804736
- The global distribution and burden of dengue
- Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GRW, Simmons CP, Scott TW, Farrar JJ, Hay SI. 2013. The global distribution and burden of dengue. Nature 496:504-507. http://dx.doi.org/10.1038/nature12060.
- (2013) Nature , vol.496 , pp. 504-507
- Bhatt, S.¹ Gething, P.W.² Brady, O.J.³ Messina, J.P.⁴ Farlow, A.W.⁵ Moyes, C.L.⁶ Drake, J.M.⁷ Brownstein, J.S.⁸ Hoen, A.G.⁹ Sankoh, O.¹⁰ Myers, M.F.¹¹ George, D.B.¹² Jaenisch, T.¹³ Wint, G.R.W.¹⁴ Simmons, C.P.¹⁵ Scott, T.W.¹⁶ Farrar, J.J.¹⁷ Hay, S.I.¹⁸

2
- 79953188722
- Small molecule inhibitors that selectively block dengue virus methyltransferase
- Lim SP, Sonntag LS, Noble C, Nilar SH, Ng RH, Zou G, Monaghan P, Chung KY, Dong H, Liu B, Bodenreider C, Lee G, Ding M, Chan WL, Wang G, Jian YL, Chao AT, Lescar J, Yin Z, Vedananda TR, Keller TH, Shi P-Y. 2011. Small molecule inhibitors that selectively block dengue virus methyltransferase. J Biol Chem 286:6233-6240. http://dx.doi.org/10.1074/jbc.M110.179184.
- (2011) J Biol Chem , vol.286 , pp. 6233-6240
- Lim, S.P.¹ Sonntag, L.S.² Noble, C.³ Nilar, S.H.⁴ Ng, R.H.⁵ Zou, G.⁶ Monaghan, P.⁷ Chung, K.Y.⁸ Dong, H.⁹ Liu, B.¹⁰ Bodenreider, C.¹¹ Lee, G.¹² Ding, M.¹³ Chan, W.L.¹⁴ Wang, G.¹⁵ Jian, Y.L.¹⁶ Chao, A.T.¹⁷ Lescar, J.¹⁸ Yin, Z.¹⁹ Vedananda, T.R.²⁰ Keller, T.H.²¹ Shi, P.-Y.²² more..

3
- 76949091459
- Strategies for development of dengue virus inhibitors
- Noble CG, Chen Y-L, Dong H, Gu F, Lim SP, Schul W, Wang Q-Y, Shi P-Y. 2010. Strategies for development of dengue virus inhibitors. Antiviral Res 85:450-462. http://dx.doi.org/10.1016/j.antiviral.2009.12.011.
- (2010) Antiviral Res , vol.85 , pp. 450-462
- Noble, C.G.¹ Chen, Y.-L.² Dong, H.³ Gu, F.⁴ Lim, S.P.⁵ Schul, W.⁶ Wang, Q.-Y.⁷ Shi, P.-Y.⁸

4
- 84872040382
- A novel inhibitor of dengue virus replication that targets the capsid protein
- Byrd CM, Dai D, Grosenbach DW, Berhanu A, Jones KF, Cardwell KB, Schneider C, Wineinger KA, Page JM, Harver C, Stavale E, Tyavanagimatt S, Stone MA, Bartenschlager R, Scaturro P, Hruby DE, Jordan R. 2013. A novel inhibitor of dengue virus replication that targets the capsid protein. Antimicrob Agents Chemother 57:15-25. http://dx.doi.org/10.1128/AAC.01429-12.
- (2013) Antimicrob Agents Chemother , vol.57 , pp. 15-25
- Byrd, C.M.¹ Dai, D.² Grosenbach, D.W.³ Berhanu, A.⁴ Jones, K.F.⁵ Cardwell, K.B.⁶ Schneider, C.⁷ Wineinger, K.A.⁸ Page, J.M.⁹ Harver, C.¹⁰ Stavale, E.¹¹ Tyavanagimatt, S.¹² Stone, M.A.¹³ Bartenschlager, R.¹⁴ Scaturro, P.¹⁵ Hruby, D.E.¹⁶ Jordan, R.¹⁷

5
- 84862165670
- The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif
- Martins IC, Gomes-Neto F, Faustino AF, Carvalho FA, Carneiro FA, Bozza PT, Mohana-Borges R, Castanho MA, Almeida FC, Santos NC, Da Poian AT. 2012. The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif. Biochem J 444: 405-415. http://dx.doi.org/10.1042/BJ20112219.
- (2012) Biochem J , vol.444 , pp. 405-415
- Martins, I.C.¹ Gomes-Neto, F.² Faustino, A.F.³ Carvalho, F.A.⁴ Carneiro, F.A.⁵ Bozza, P.T.⁶ Mohana-Borges, R.⁷ Castanho, M.A.⁸ Almeida, F.C.⁹ Santos, N.C.¹⁰ Da Poian, A.T.¹¹

6
- 66149086118
- A small-molecule dengue virus entry inhibitor
- Wang Q-Y, Patel SJ, Vangrevelinghe E, Xu HY, Rao R, Jaber D, Schul W, Gu F, Heudi O, Ma NL, Poh MK, Phong WY, Keller TH, Jacoby E, Vasudevan SG. 2009. A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother 53:1823-1831. http://dx.doi.org/10.1128/AAC.01148-08.
- (2009) Antimicrob Agents Chemother , vol.53 , pp. 1823-1831
- Wang, Q.-Y.¹ Patel, S.J.² Vangrevelinghe, E.³ Xu, H.Y.⁴ Rao, R.⁵ Jaber, D.⁶ Schul, W.⁷ Gu, F.⁸ Heudi, O.⁹ Ma, N.L.¹⁰ Poh, M.K.¹¹ Phong, W.Y.¹² Keller, T.H.¹³ Jacoby, E.¹⁴ Vasudevan, S.G.¹⁵

7
- 84871380932
- Characterization of 8-hydroxyquinoline derivatives containing aminobenzothiazole as inhibitors of dengue virus type 2 protease in vitro
- Lai H, Sridhar Prasad G, Padmanabhan R. 2013. Characterization of 8-hydroxyquinoline derivatives containing aminobenzothiazole as inhibitors of dengue virus type 2 protease in vitro. Antiviral Res 97:74-80. http://dx.doi.org/10.1016/j.antiviral.2012.10.009.
- (2013) Antiviral Res , vol.97 , pp. 74-80
- Lai, H.¹ Sridhar Prasad, G.² Padmanabhan, R.³

8
- 84867236960
- Structural biology of dengue virus enzymes: Towards rational design of therapeutics
- Noble CG, Shi P-Y. 2012. Structural biology of dengue virus enzymes: towards rational design of therapeutics. Antiviral Res 96:115-126. http://dx.doi.org/10.1016/j.antiviral.2012.09.007.
- (2012) Antiviral Res , vol.96 , pp. 115-126
- Noble, C.G.¹ Shi, P.-Y.²

9
- 84879246944
- Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication
- van Cleef KWR, Overheul GJ, Thomassen MC, Kaptein SJF, Davidson AD, Jacobs M, Neyts J, van Kuppeveld FJM, van Rij RP. 2013. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication. Antiviral Res 99:165-171. http://dx.doi.org/10.1016/j.antiviral.2013.05.011.
- (2013) Antiviral Res , vol.99 , pp. 165-171
- Van Cleef, K.W.R.¹ Overheul, G.J.² Thomassen, M.C.³ Kaptein, S.J.F.⁴ Davidson, A.D.⁵ Jacobs, M.⁶ Neyts, J.⁷ Van Kuppeveld, F.J.M.⁸ Van Rij, R.P.⁹

10
- 80055106240
- Inhibition of dengue virus by targeting viral NS4B protein
- Xie X, Wang Q-Y, Xu HY, Qing M, Kramer L, Yuan Z, Shi P-Y. 2011. Inhibition of dengue virus by targeting viral NS4B protein. J Virol 85: 11183-11195. http://dx.doi.org/10.1128/JVI.05468-11.
- (2011) J Virol , vol.85 , pp. 11183-11195
- Xie, X.¹ Wang, Q.-Y.² Xu, H.Y.³ Qing, M.⁴ Kramer, L.⁵ Yuan, Z.⁶ Shi, P.-Y.⁷

11
- 35348920605
- Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2′O)-methyltransferase
- Luzhkov VB, Selisko B, Nordqvist A, Peyrane F, Decroly E, Alvarez K, Karlen A, Canard B, Qvist J. 2007. Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2′O)-methyltransferase. Bioorg Med Chem 15:7795-7802. http://dx.doi.org/10.1016/j.bmc.2007.08.049.
- (2007) Bioorg Med Chem , vol.15 , pp. 7795-7802
- Luzhkov, V.B.¹ Selisko, B.² Nordqvist, A.³ Peyrane, F.⁴ Decroly, E.⁵ Alvarez, K.⁶ Karlen, A.⁷ Canard, B.⁸ Qvist, J.⁹

12
- 77955363550
- Inhibition of dengue virus by an ester prodrug of an adenosine analog
- Chen Y-L, Yin Z, Lakshminarayana SB, Qing M, Schul W, Duraiswamy J, Kondreddi RR, Goh A, Xu HY, Yip A, Liu B, Weaver M, Dartois V, Keller TH, Shi P-Y. 2010. Inhibition of dengue virus by an ester prodrug of an adenosine analog. Antimicrob Agents Chemother 54:3255-3261. http://dx.doi.org/10.1128/AAC.00397-10.
- (2010) Antimicrob Agents Chemother , vol.54 , pp. 3255-3261
- Chen, Y.-L.¹ Yin, Z.² Lakshminarayana, S.B.³ Qing, M.⁴ Schul, W.⁵ Duraiswamy, J.⁶ Kondreddi, R.R.⁷ Goh, A.⁸ Xu, H.Y.⁹ Yip, A.¹⁰ Liu, B.¹¹ Weaver, M.¹² Dartois, V.¹³ Keller, T.H.¹⁴ Shi, P.-Y.¹⁵

13
- 84875997317
- A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients
- Nguyen NM, Tran CNB, Phung LK, Duong KTH, Huynh HLA, Farrar J, Nguyen QTH, Tran HT, Nguyen CVV, Merson L, Hoang LT, Hibberd ML, Aw PPK, Wilm A, Nagarajan N, Nguyen DT, Pham MP, Nguyen TT, Javanbakht H, Klumpp K, Hammond J, Petric R, Wolbers M, Nguyen CT, Simmons CP. 2013. A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis 207:1442-1450. http://dx.doi.org/10.1093/infdis/jis470.
- (2013) J Infect Dis , vol.207 , pp. 1442-1450
- Nguyen, N.M.¹ Tran, C.N.B.² Phung, L.K.³ Duong, K.T.H.⁴ Huynh, H.L.A.⁵ Farrar, J.⁶ Nguyen, Q.T.H.⁷ Tran, H.T.⁸ Nguyen, C.V.V.⁹ Merson, L.¹⁰ Hoang, L.T.¹¹ Hibberd, M.L.¹² Aw, P.P.K.¹³ Wilm, A.¹⁴ Nagarajan, N.¹⁵ Nguyen, D.T.¹⁶ Pham, M.P.¹⁷ Nguyen, T.T.¹⁸ Javanbakht, H.¹⁹ Klumpp, K.²⁰ more..

14
- 77951984630
- Inhibition of dengue virus polymerase by blocking of the RNA tunnel
- Niyomrattanakit P, Chen Y-L, Dong H, Yin Z, Qing M, Glickman JF, Lin K, Mueller D, Voshol H, Lim JYH, Nilar S, Keller TH, Shi P-Y. 2010. Inhibition of dengue virus polymerase by blocking of the RNA tunnel. J Virol 84:5678-5686. http://dx.doi.org/10.1128/JVI.02451-09.
- (2010) J Virol , vol.84 , pp. 5678-5686
- Niyomrattanakit, P.¹ Chen, Y.-L.² Dong, H.³ Yin, Z.⁴ Qing, M.⁵ Glickman, J.F.⁶ Lin, K.⁷ Mueller, D.⁸ Voshol, H.⁹ Lim, J.Y.H.¹⁰ Nilar, S.¹¹ Keller, T.H.¹² Shi, P.-Y.¹³

15
- 84876340250
- Conformational flexibility of the dengue virus RNA-dependent RNA polymerase revealed by a complex with an inhibitor
- Noble CG, Lim SP, Chen Y-L, Liew CW, Yap L, Lescar J, Shi P-Y. 2013. Conformational flexibility of the dengue virus RNA-dependent RNA polymerase revealed by a complex with an inhibitor. J Virol 87:5291-5295. http://dx.doi.org/10.1128/JVI.00045-13.
- (2013) J Virol , vol.87 , pp. 5291-5295
- Noble, C.G.¹ Lim, S.P.² Chen, Y.-L.³ Liew, C.W.⁴ Yap, L.⁵ Lescar, J.⁶ Shi, P.-Y.⁷

16
- 73949141554
- An adenosine nucleoside inhibitor of dengue virus
- Yin Z, Chen Y-L, Schul W, Wang Q-Y, Gu F, Duraiswamy J, Kondreddi RR, Niyomrattanakit P, Lakshminarayana SB, Goh A, Xu HY, Liu W, Liu B, Lim JYH, Ng CY, Qing M, Lim CC, Yip A, Wang G, Chan WL, Tan HP, Lin K, Zhang B, Zou G, Bernard KA, Garrett C, Beltz K, Dong M, Weaver M, He H, Pichota A, Dartois V, Keller TH, Shi P-Y. 2009. An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci U S A 106:20435-20439. http://dx.doi.org/10.1073/pnas.0907010106.
- (2009) Proc Natl Acad Sci U S A , vol.106 , pp. 20435-20439
- Yin, Z.¹ Chen, Y.-L.² Schul, W.³ Wang, Q.-Y.⁴ Gu, F.⁵ Duraiswamy, J.⁶ Kondreddi, R.R.⁷ Niyomrattanakit, P.⁸ Lakshminarayana, S.B.⁹ Goh, A.¹⁰ Xu, H.Y.¹¹ Liu, W.¹² Liu, B.¹³ Lim, J.Y.H.¹⁴ Ng, C.Y.¹⁵ Qing, M.¹⁶ Lim, C.C.¹⁷ Yip, A.¹⁸ Wang, G.¹⁹ Chan, W.L.²⁰ more..

17
- 84864925701
- Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial
- Watanabe S, Rathore APS, Sung C, Lu F, Khoo YM, Connolly J, Low J, Ooi EE, Lee HS, Vasudevan SG. 2012. Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial. Antiviral Res 96:32-35. http://dx.doi.org/10.1016/j.antiviral.2012.07.008.
- (2012) Antiviral Res , vol.96 , pp. 32-35
- Watanabe, S.¹ Rathore, A.P.S.² Sung, C.³ Lu, F.⁴ Khoo, Y.M.⁵ Connolly, J.⁶ Low, J.⁷ Ooi, E.E.⁸ Lee, H.S.⁹ Vasudevan, S.G.¹⁰

18
- 84868235874
- Lovastatin for adult patients with dengue: Protocol for a randomised controlled trial
- Whitehorn J, Van Vinh Chau N, Truong NT, Tai LTH, Van Hao N, Hien TT, Wolbers M, Merson L, Dung NTP, Peeling R, Simmons C, Wills B, Farrar J. 2012. Lovastatin for adult patients with dengue: protocol for a randomised controlled trial. Trials 13:203. http://dx.doi.org/10.1186/1745-6215-13-203.
- (2012) Trials , vol.13 , pp. 203
- Whitehorn, J.¹ Van Vinh-Chau, N.² Truong, N.T.³ Tai, L.T.H.⁴ Van Hao, N.⁵ Hien, T.T.⁶ Wolbers, M.⁷ Merson, L.⁸ Dung, N.T.P.⁹ Peeling, R.¹⁰ Simmons, C.¹¹ Wills, B.¹² Farrar, J.¹³

19
- 78149265507
- A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults
- Tricou V, Minh NN, Van TP, Lee SJ, Farrar J, Wills B, Tran HT, Simmons CP. 2010. A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis 4:e785. http://dx.doi.org/10.1371/journal.pntd.0000785.
- (2010) PLoS Negl Trop Dis , vol.4 , pp. e785
- Tricou, V.¹ Minh, N.N.² Van, T.P.³ Lee, S.J.⁴ Farrar, J.⁵ Wills, B.⁶ Tran, H.T.⁷ Simmons, C.P.⁸

20
- 84867518076
- Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: A randomized, placebo-controlled trial
- Tam DTH, Ngoc TV, Tien NTH, Kieu NTT, Thuy TTT, Thanh LTC, Tam CT, Truong NT, Dung NT, Qui PT, Hien TT, Farrar JJ, Simmons CP, Wolbers M, Wills BA. 2012. Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis 55:1216-1224. http://dx.doi.org/10.1093/cid/cis655.
- (2012) Clin Infect Dis , vol.55 , pp. 1216-1224
- Tam, D.T.H.¹ Ngoc, T.V.² Tien, N.T.H.³ Kieu, N.T.T.⁴ Thuy, T.T.T.⁵ Thanh, L.T.C.⁶ Tam, C.T.⁷ Truong, N.T.⁸ Dung, N.T.⁹ Qui, P.T.¹⁰ Hien, T.T.¹¹ Farrar, J.J.¹² Simmons, C.P.¹³ Wolbers, M.¹⁴ Wills, B.A.¹⁵

21
- 0035738110
- Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro
- Smee DF, Bray M, Huggins JW. 2001. Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro. Antivir Chem Chemother 12:327-335.
- (2001) Antivir Chem Chemother , vol.12 , pp. 327-335
- Smee, D.F.¹ Bray, M.² Huggins, J.W.³

22
- 0037846089
- Imported lassa fever in Germany: Surveillance and management of contact persons
- Haas WH, Breuer T, Pfaff G, Schmitz H, Köhler P, Asper M, Emmerich P, Drosten C, Gölnitz U, Fleischer K, Günther S. 2003. Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis 36:1254-1258. http://dx.doi.org/10.1086/374853.
- (2003) Clin Infect Dis , vol.36 , pp. 1254-1258
- Haas, W.H.¹ Breuer, T.² Pfaff, G.³ Schmitz, H.⁴ Köhler, P.⁵ Asper, M.⁶ Emmerich, P.⁷ Drosten, C.⁸ Gölnitz, U.⁹ Fleischer, K.¹⁰ Günther, S.¹¹

23
- 0019471668
- Inhibitors of IMP dehydrogenase prevent Sindbis virus replication and reduce GTP levels in Aedes albopictus cells
- Malinoski F, Stollar V. 1981. Inhibitors of IMP dehydrogenase prevent Sindbis virus replication and reduce GTP levels in Aedes albopictus cells. Virology 110:281-289. http://dx.doi.org/10.1016/0042-6822(81)90060-X.
- (1981) Virology , vol.110 , pp. 281-289
- Malinoski, F.¹ Stollar, V.²

24
- 13744258758
- The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase
- Leyssen P, Balzarini J, De Clercq E, Neyts J. 2005. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. J Virol 79:1943-1947. http://dx.doi.org/10.1128/JVI.79.3.1943-1947.2005.
- (2005) J Virol , vol.79 , pp. 1943-1947
- Leyssen, P.¹ Balzarini, J.² De Clercq, E.³ Neyts, J.⁴

25
- 0035811016
- RNA virus error catastrophe: Direct molecular test by using ribavirin
- Crotty S, Cameron CE, Andino R. 2001. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci USA 98:6895-6900. http://dx.doi.org/10.1073/pnas.111085598.
- (2001) Proc Natl Acad Sci USA , vol.98 , pp. 6895-6900
- Crotty, S.¹ Cameron, C.E.² Andino, R.³

26
- 78751545582
- Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models
- Thomas E, Feld JJ, Li Q, Hu Z, Fried MW, Liang TJ. 2011. Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models. Hepatology 53:32-41. http://dx.doi.org/10.1002/hep.23985.
- (2011) Hepatology , vol.53 , pp. 32-41
- Thomas, E.¹ Feld, J.J.² Li, Q.³ Hu, Z.⁴ Fried, M.W.⁵ Liang, T.J.⁶

27
- 77956123412
- Characterization of dengue virus resistance to brequinar in cell culture
- Qing M, Zou G, Wang Q-Y, Xu HY, Dong H, Yuan Z, Shi P-Y. 2010. Characterization of dengue virus resistance to brequinar in cell culture. Antimicrob Agents Chemother 54:3686-3695. http://dx.doi.org/10.1128/AAC.00561-10.
- (2010) Antimicrob Agents Chemother , vol.54 , pp. 3686-3695
- Qing, M.¹ Zou, G.² Wang, Q.-Y.³ Xu, H.Y.⁴ Dong, H.⁵ Yuan, Z.⁶ Shi, P.-Y.⁷

28
- 80051822664
- Inhibition of dengue virus through suppression of host pyrimidine biosynthesis
- Wang Q-Y, Bushell S, Qing M, Xu HY, Bonavia A, Nunes S, Zhou J, Poh MK, Florez de Sessions P, Niyomrattanakit P, Dong H, Hoffmaster K, Goh A, Nilar S, Schul W, Jones S, Kramer L, Compton T, Shi P-Y. 2011. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis. J Virol 85:6548-6556. http://dx.doi.org/10.1128/JVI.02510-10.
- (2011) J Virol , vol.85 , pp. 6548-6556
- Wang, Q.-Y.¹ Bushell, S.² Qing, M.³ Xu, H.Y.⁴ Bonavia, A.⁵ Nunes, S.⁶ Zhou, J.⁷ Poh, M.K.⁸ Florez De-Sessions, P.⁹ Niyomrattanakit, P.¹⁰ Dong, H.¹¹ Hoffmaster, K.¹² Goh, A.¹³ Nilar, S.¹⁴ Schul, W.¹⁵ Jones, S.¹⁶ Kramer, L.¹⁷ Compton, T.¹⁸ Shi, P.-Y.¹⁹

29
- 0034650342
- Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents
- Liu S, Neidhardt EA, Grossman TH, Ocain T, Clardy J. 2000. Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. Structure 8:25-33. http://dx.doi.org/10.1016/S0969-2126 (00)00077-0.
- (2000) Structure , vol.8 , pp. 25-33
- Liu, S.¹ Neidhardt, E.A.² Grossman, T.H.³ Ocain, T.⁴ Clardy, J.⁵

30
- 0032958286
- Inhibitors of dihydroorotate dehydrogenase
- Batt DG. 1999. Inhibitors of dihydroorotate dehydrogenase. Expert Opin Ther Pat 9:41-54. http://dx.doi.org/10.1517/13543776.9.1.41.
- (1999) Expert Opin Ther Pat , vol.9 , pp. 41-54
- Batt, D.G.¹

31
- 35349023246
- Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing
- Ng CY, Gu F, Phong WY, Chen Y-L, Lim SP, Davidson A, Vasudevan SG. 2007. Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing. Antiviral Res 76:222-231. http://dx.doi.org/10.1016/j.antiviral.2007.06.007.
- (2007) Antiviral Res , vol.76 , pp. 222-231
- Ng, C.Y.¹ Gu, F.² Phong, W.Y.³ Chen, Y.-L.⁴ Lim, S.P.⁵ Davidson, A.⁶ Vasudevan, S.G.⁷

32
- 67650488269
- Synergistic drug combinations tend to improve therapeutically relevant selectivity
- Lehár J, Krueger AS, Avery W, Heilbut AM, Johansen LM, Price ER, Rickles RJ, Short GF, Staunton JE, Jin X, Lee MS, Zimmermann GR, Borisy AA. 2009. Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol 27:659-666. http://dx.doi.org/10.1038/nbt.1549.
- (2009) Nat Biotechnol , vol.27 , pp. 659-666
- Lehár, J.¹ Krueger, A.S.² Avery, W.³ Heilbut, A.M.⁴ Johansen, L.M.⁵ Price, E.R.⁶ Rickles, R.J.⁷ Short, G.F.⁸ Staunton, J.E.⁹ Jin, X.¹⁰ Lee, M.S.¹¹ Zimmermann, G.R.¹² Borisy, A.A.¹³

33
- 33748794547
- Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
- Chou T-C. 2006. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621-681. http://dx.doi.org/10.1124/pr.58.3.10.
- (2006) Pharmacol Rev , vol.58 , pp. 621-681
- Chou, T.-C.¹

34
- 15944377364
- Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: Comparison of different drug interaction models
- Meletiadis J, Verweij PE, TeDorsthorst DT, Meis JF, Mouton JW. 2005. Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models. Med Mycol 43:133-152. http://dx.doi.org/10.1080/13693780410001731547.
- (2005) Med Mycol , vol.43 , pp. 133-152
- Meletiadis, J.¹ Verweij, P.E.² Tedorsthorst, D.T.³ Meis, J.F.⁴ Mouton, J.W.⁵

35
- 84873326152
- Understanding synergy
- Geary N. 2013. Understanding synergy. Am J Physiol Endocrinol Metab 304:E237-E253. http://dx.doi.org/10.1152/ajpendo.00308.2012.
- (2013) Am J Physiol Endocrinol Metab , vol.304 , pp. E237-E253
- Geary, N.¹

36
- 84861578651
- Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis Cvirus infection in vitro and in vivo
- Pan Q, de Ruiter PE, Metselaar HJ, Kwekkeboom J, de Jonge J, Tilanus HW, Janssen HLA, van der Laan LJW. 2012. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis Cvirus infection in vitro and in vivo. Hepatology 55:1673-1683. http://dx.doi.org/10.1002/hep.25562.
- (2012) Hepatology , vol.55 , pp. 1673-1683
- Pan, Q.¹ De Ruiter, P.E.² Metselaar, H.J.³ Kwekkeboom, J.⁴ De Jonge, J.⁵ Tilanus, H.W.⁶ Janssen, H.L.A.⁷ Van Der-Laan, L.J.W.⁸

37
- 84903774295
- Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus
- Gentile I, Coppola N, Buonomo AR, Zappulo E, Borgia G. 2014. Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus. Expert Opin Investig Drugs 23:1211-1223. http://dx.doi.org/10.1517/13543784.2014.921680.
- (2014) Expert Opin Investig Drugs , vol.23 , pp. 1211-1223
- Gentile, I.¹ Coppola, N.² Buonomo, A.R.³ Zappulo, E.⁴ Borgia, G.⁵

38
- 79955529751
- INX-08189, a phosphoramidate prodrug of 6-O-methyl-2′-C-methyl guanosine, is a potent inhibitor of hepatitis C virus replication with excellent pharmacokinetic and pharmacodynamic properties
- Vernachio JH, Bleiman B, Bryant KD, Chamberlain S, Hunley D, Hutchins J, Ames B, Gorovits E, Ganguly B, Hall A, Kolykhalov A, Liu Y, Muhammad J, Raja N, Walters CR, Wang J, Williams K, Patti JM, Henson G, Madela K, Aljarah M, Gilles A, McGuigan C. 2011. INX-08189, a phosphoramidate prodrug of 6-O-methyl-2′-C-methyl guanosine, is a potent inhibitor of hepatitis C virus replication with excellent pharmacokinetic and pharmacodynamic properties. Antimicrob Agents Chemother 55:1843-1851. http://dx.doi.org/10.1128/AAC.01335-10.
- (2011) Antimicrob Agents Chemother , vol.55 , pp. 1843-1851
- Vernachio, J.H.¹ Bleiman, B.² Bryant, K.D.³ Chamberlain, S.⁴ Hunley, D.⁵ Hutchins, J.⁶ Ames, B.⁷ Gorovits, E.⁸ Ganguly, B.⁹ Hall, A.¹⁰ Kolykhalov, A.¹¹ Liu, Y.¹² Muhammad, J.¹³ Raja, N.¹⁴ Walters, C.R.¹⁵ Wang, J.¹⁶ Williams, K.¹⁷ Patti, J.M.¹⁸ Henson, G.¹⁹ Madela, K.²⁰ more..

39
- 0034110319
- Potentiation of the anti-HIV activity of zalcitabine and lamivudine by a CTP synthase inhibitor, 3-deazauridine
- Gao WY, Johns DG, Mitsuya H. 2000. Potentiation of the anti-HIV activity of zalcitabine and lamivudine by a CTP synthase inhibitor, 3-deazauridine. Nucleosides Nucleotides Nucleic Acids 19:371-377. http://dx.doi.org/10.1080/15257770008033015.
- (2000) Nucleosides Nucleotides Nucleic Acids , vol.19 , pp. 371-377
- Gao, W.Y.¹ Johns, D.G.² Mitsuya, H.³

40
- 33645396484
- Functional classification of drugs by properties of their pairwise interactions
- Yeh P, Tschumi AI, Kishony R. 2006. Functional classification of drugs by properties of their pairwise interactions. Nat Genet 38:489-494. http://dx.doi.org/10.1038/ng1755.
- (2006) Nat Genet , vol.38 , pp. 489-494
- Yeh, P.¹ Tschumi, A.I.² Kishony, R.³

41
- 84892474741
- Activation of peripheral blood mononuclear cells by dengue virus infection depotentiates balapiravir
- Chen Y-L, Abdul Ghafar N, Karuna R, Fu Y, Lim SP, Schul W, Gu F, Herve M, Yokohama F, Wang G, Cerny D, Fink K, Blasco F, Shi P-Y. 2014. Activation of peripheral blood mononuclear cells by dengue virus infection depotentiates balapiravir. J Virol 88:1740-1747. http://dx.doi.org/10.1128/JVI.02841-13.
- (2014) J Virol , vol.88 , pp. 1740-1747
- Chen, Y.-L.¹ Abdul Ghafar, N.² Karuna, R.³ Fu, Y.⁴ Lim, S.P.⁵ Schul, W.⁶ Gu, F.⁷ Herve, M.⁸ Yokohama, F.⁹ Wang, G.¹⁰ Cerny, D.¹¹ Fink, K.¹² Blasco, F.¹³ Shi, P.-Y.¹⁴

42
- 84860536610
- Susceptibility and response of human blood monocyte subsets to primary dengue virus infection
- Wong KL, Chen W, Balakrishnan T, Toh YX, Fink K, Wong S-C. 2012. Susceptibility and response of human blood monocyte subsets to primary dengue virus infection. PLoS One 7:e36435. http://dx.doi.org/10.1371/journal.pone.0036435.
- (2012) PLoS One , vol.7 , pp. e36435
- Wong, K.L.¹ Chen, W.² Balakrishnan, T.³ Toh, Y.X.⁴ Fink, K.⁵ Wong, S.-C.⁶

43
- 84904762644
- Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): A phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
- Low JG, Sung C, Wijaya L, Wei Y, Rathore APS, Watanabe S, Tan BH, Toh L, Chua LT, Hou Y, Chow A, Howe S, Chan WK, Tan KH, Chung JS, Cherng BP, Lye DC, Tambayah PA, Ng LC, Connolly J, Hibberd ML, Leo YS, Cheung YB, Ooi EE, Vasudevan SG. 2014. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infect Dis 14:706-715. http://dx.doi.org/10.1016/S1473-3099 (14)70730-3.
- (2014) Lancet Infect Dis , vol.14 , pp. 706-715
- Low, J.G.¹ Sung, C.² Wijaya, L.³ Wei, Y.⁴ Rathore, A.P.S.⁵ Watanabe, S.⁶ Tan, B.H.⁷ Toh, L.⁸ Chua, L.T.⁹ Hou, Y.¹⁰ Chow, A.¹¹ Howe, S.¹² Chan, W.K.¹³ Tan, K.H.¹⁴ Chung, J.S.¹⁵ Cherng, B.P.¹⁶ Lye, D.C.¹⁷ Tambayah, P.A.¹⁸ Ng, L.C.¹⁹ Connolly, J.²⁰ more..

44
- 33747620519
- Systems biology and combination therapy in the quest for clinical efficacy
- Fitzgerald JB, Schoeberl B, Nielsen UB, Sorger PK. 2006. Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol 2:458-466. http://dx.doi.org/10.1038/nchembio817.
- (2006) Nat Chem Biol , vol.2 , pp. 458-466
- Fitzgerald, J.B.¹ Schoeberl, B.² Nielsen, U.B.³ Sorger, P.K.⁴

45
- 77953237918
- Chemical combinations elucidate pathway interactions and regulation relevant to hepatitis C replication
- Owens CM, Mawhinney C, Grenier JM, Altmeyer R, Lee MS, Borisy AA, Lehár J, Johansen LM. 2010. Chemical combinations elucidate pathway interactions and regulation relevant to hepatitis C replication. Mol Syst Biol 6:375. http://dx.doi.org/10.1038/msb.2010.32.
- (2010) Mol Syst Biol , vol.6 , pp. 375
- Owens, C.M.¹ Mawhinney, C.² Grenier, J.M.³ Altmeyer, R.⁴ Lee, M.S.⁵ Borisy, A.A.⁶ Lehár, J.⁷ Johansen, L.M.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.